While only 5.1 percent of COVID-19 patients admitted to intensive care units had severe gastrointestinal complications, those patients had a mortality rate of 55.6 percent, according to a pre-proof study published in Gastroenterology.
GI & Endoscopy
Gastroenterologist and colorectal cancer screening pioneer David Ahlquist, MD, died Nov. 1 of amyotrophic lateral sclerosis. He was 69.
Oceanside, N.Y.-based Mount Sinai South Nassau broke ground on a 15,400-square-foot facility in Long Beach, N.Y., the health system announced Nov. 10.
The FDA approved Sebela Pharmaceuticals' colonoscopy preparation tablet Sutab, the company announced Nov. 10.
Here are the five most-read stories about gastroenterology and endoscopy from Nov. 5-13:
Researchers developed a model that can predict an individual patient's risk to develop advanced precancerous polyps and colon cancer, Medical Xpress reported Nov. 10.
Here are 10 updates from gastroenterology companies and practices in the last week:
Three physicians recently completed the first robotic-assisted colon resection surgeries at Martinsburg, W.Va.-based Berkeley Medical Center.
Docbot's artificial intelligence platform can be trained to predict levels of ulcerative colitis severity after reviewing full-length endoscopy videos, AiThority reported Nov. 6.
Ellen Scherl, MD, research director of the Jill Roberts Center for Inflammatory Bowel Disease at New York City-based Weill Cornell Medicine, spoke with NextServices President Praveen Suthrum about the future of the specialty.
